Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Is neoadjuvant chemoradiotherapy a feasible strategy for stage IIIA-N2 non-small cell lung cancer? Mature results of the randomized IFCT-0101 phase II trial.

Is neoadjuvant chemoradiotherapy a feasible strategy for stage IIIA-N2 non-small cell lung... http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Lung Cancer Pubmed

Is neoadjuvant chemoradiotherapy a feasible strategy for stage IIIA-N2 non-small cell lung cancer? Mature results of the randomized IFCT-0101 phase II trial.

Loading next page...
 
/lp/pubmed/is-neoadjuvant-chemoradiotherapy-a-feasible-strategy-for-stage-iiia-n2-a1s0lpJbyU

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

ISSN
0169-5002
DOI
10.1016/j.lungcan.2009.10.003
pmid
19879013

Abstract

Journal

Lung CancerPubmed

Published: Nov 3, 2010

There are no references for this article.